Vaccine stocks surge as WHO declares a global emergency over the mpox outbreak.
The market’s disturbing response to human suffering highlights an uncomfortable truth.
The mpox crisis raises the usual questions about profit motives in healthcare.
As the WHO declares a global health emergency over the mpox outbreak,
vaccine makers' stocks are surging. Is profiting from human misery the new
normal?
The Grim Reality: Mpox and the Surge in Vaccine Stocks
The recent declaration of a global health emergency by the World Health
Organization (WHO) in response to the escalating mpox outbreak in Africa has
sent shockwaves through the financial markets. But, alongside the cry
for humanitarian aid and global cooperation, the immediate reaction from the
markets was a surge in vaccine company stocks as investors and traders sought to benefit from the surge in demand. This isn’t a blip on the radar,
it’s a clear example of how the market capitalizes on crises, with a chilling
focus on human suffering.
As investors rush to capitalize on the potential windfall from the
crisis, shares in vaccine manufacturers have soared. Companies like Bavarian
Nordic and Emergent BioSolutions have seen significant
upticks in their stock prices following the WHO's emergency declaration.
Bavarian Nordic, which produces the only FDA-approved vaccine for mpox,
witnessed a surge in its stock value, while Emergent BioSolutions, a key player
in vaccine production, saw similar gains. Other companies producing medical
tools used in the production or administration of vaccines have also seen
upticks.
Profiting from Misery
Let’s not mince words: the market’s enthusiastic response to the mpox
emergency is pretty grim, though predictable. It's a stark reminder of how the
financial system often operates with a moral compass that’s spinning wildly out
of control. The surge in vaccine stocks isn't about hope or relief; it’s about
profit—cold, hard cash made off the back of a public health crisis.
This pattern is nothing new. The pharmaceutical industry has a long
history of reaping massive profits from global health crises. The Covid-19
pandemic was a prime example, with companies like Pfizer and
Moderna enjoying unprecedented stock gains. But the current response to the
mpox outbreak feels even more unsettling, given the slow, inadequate response
to the needs of those suffering from the disease.
Remembering Martin Shkreli
If this all sounds familiar, it’s because it is. Just consider the case
of Martin Shkreli and the infamous Daraprim price hike. In 2015, Shkreli, then
CEO of Turing Pharmaceuticals, jacked up the price of Daraprim—a life-saving
drug used to treat parasitic infections—from $13.50 to $750 per pill overnight.
The public outrage was swift, but so was the financial windfall for Shkreli, a
famed lover of Kayne West, and his company.
The conditions are different, for sure, but the idea of actively profiting
off suffering, especially given the curative nature of the products produced by
the vaccine manufacturers, makes it stick in the throat. One key difference? This
time, it’s the entire market that’s jumping on the bandwagon, making the
exploitation of a public health crisis a norm rather than an anomaly.
The Mpox Emergency: A Lesson in Unchecked Capitalism
The current surge in vaccine stocks raises uncomfortable questions
about the nature of capitalism, particularly in the healthcare sector. When the
market rewards companies for merely being in the right place at the right time,
it becomes clear that profit, not people, is the driving force.
The WHO’s declaration of a global health emergency over the mpox
outbreak was meant to mobilize resources, encourage cooperation, and prompt
action, it wasn’t meant to be an indication that investors should line their
pockets. This is not just an indictment of the market, but of the entire
economic system that allows such behavior to thrive.
Looking Forward
So, where do we go from here? For starters, it’s crucial to recognize
that the current model of profit-driven healthcare is fundamentally flawed.
When life-saving treatments and vaccines are treated as commodities rather than
public goods, the result is a system that prioritizes profit over people.
There’s a pressing need for stronger regulation and oversight to ensure
that the healthcare industry serves the public interest rather than that of the
shareholders. This could include measures such as price controls on essential
medicines, stricter regulations on pharmaceutical patents, and greater
transparency in pricing.
But beyond policy changes, there needs to be a cultural shift—a
rethinking of the values that underpin our economic system. The idea that it’s
acceptable to profit from human suffering should be rejected outright. We need
to move towards a model of healthcare that is centered on equity, access, and
the well-being of all people, not just the bottom line.
We can but hope, right?
To wrap it all up, the surge in vaccine stocks following the mpox emergency
declaration is a disturbing reflection of our times. It highlights a systemic
problem where human suffering is just another opportunity for profit. As we
navigate through this crisis, it’s crucial to ask ourselves: what kind of
society do we want to be? One that profits from pain, or one that prioritizes
people over profit?
For more finance-adjacent stories, follow our Trending section.
As the WHO declares a global health emergency over the mpox outbreak,
vaccine makers' stocks are surging. Is profiting from human misery the new
normal?
The Grim Reality: Mpox and the Surge in Vaccine Stocks
The recent declaration of a global health emergency by the World Health
Organization (WHO) in response to the escalating mpox outbreak in Africa has
sent shockwaves through the financial markets. But, alongside the cry
for humanitarian aid and global cooperation, the immediate reaction from the
markets was a surge in vaccine company stocks as investors and traders sought to benefit from the surge in demand. This isn’t a blip on the radar,
it’s a clear example of how the market capitalizes on crises, with a chilling
focus on human suffering.
As investors rush to capitalize on the potential windfall from the
crisis, shares in vaccine manufacturers have soared. Companies like Bavarian
Nordic and Emergent BioSolutions have seen significant
upticks in their stock prices following the WHO's emergency declaration.
Bavarian Nordic, which produces the only FDA-approved vaccine for mpox,
witnessed a surge in its stock value, while Emergent BioSolutions, a key player
in vaccine production, saw similar gains. Other companies producing medical
tools used in the production or administration of vaccines have also seen
upticks.
Profiting from Misery
Let’s not mince words: the market’s enthusiastic response to the mpox
emergency is pretty grim, though predictable. It's a stark reminder of how the
financial system often operates with a moral compass that’s spinning wildly out
of control. The surge in vaccine stocks isn't about hope or relief; it’s about
profit—cold, hard cash made off the back of a public health crisis.
This pattern is nothing new. The pharmaceutical industry has a long
history of reaping massive profits from global health crises. The Covid-19
pandemic was a prime example, with companies like Pfizer and
Moderna enjoying unprecedented stock gains. But the current response to the
mpox outbreak feels even more unsettling, given the slow, inadequate response
to the needs of those suffering from the disease.
Remembering Martin Shkreli
If this all sounds familiar, it’s because it is. Just consider the case
of Martin Shkreli and the infamous Daraprim price hike. In 2015, Shkreli, then
CEO of Turing Pharmaceuticals, jacked up the price of Daraprim—a life-saving
drug used to treat parasitic infections—from $13.50 to $750 per pill overnight.
The public outrage was swift, but so was the financial windfall for Shkreli, a
famed lover of Kayne West, and his company.
The conditions are different, for sure, but the idea of actively profiting
off suffering, especially given the curative nature of the products produced by
the vaccine manufacturers, makes it stick in the throat. One key difference? This
time, it’s the entire market that’s jumping on the bandwagon, making the
exploitation of a public health crisis a norm rather than an anomaly.
The Mpox Emergency: A Lesson in Unchecked Capitalism
The current surge in vaccine stocks raises uncomfortable questions
about the nature of capitalism, particularly in the healthcare sector. When the
market rewards companies for merely being in the right place at the right time,
it becomes clear that profit, not people, is the driving force.
The WHO’s declaration of a global health emergency over the mpox
outbreak was meant to mobilize resources, encourage cooperation, and prompt
action, it wasn’t meant to be an indication that investors should line their
pockets. This is not just an indictment of the market, but of the entire
economic system that allows such behavior to thrive.
Looking Forward
So, where do we go from here? For starters, it’s crucial to recognize
that the current model of profit-driven healthcare is fundamentally flawed.
When life-saving treatments and vaccines are treated as commodities rather than
public goods, the result is a system that prioritizes profit over people.
There’s a pressing need for stronger regulation and oversight to ensure
that the healthcare industry serves the public interest rather than that of the
shareholders. This could include measures such as price controls on essential
medicines, stricter regulations on pharmaceutical patents, and greater
transparency in pricing.
But beyond policy changes, there needs to be a cultural shift—a
rethinking of the values that underpin our economic system. The idea that it’s
acceptable to profit from human suffering should be rejected outright. We need
to move towards a model of healthcare that is centered on equity, access, and
the well-being of all people, not just the bottom line.
We can but hope, right?
To wrap it all up, the surge in vaccine stocks following the mpox emergency
declaration is a disturbing reflection of our times. It highlights a systemic
problem where human suffering is just another opportunity for profit. As we
navigate through this crisis, it’s crucial to ask ourselves: what kind of
society do we want to be? One that profits from pain, or one that prioritizes
people over profit?
For more finance-adjacent stories, follow our Trending section.
Louis Parks has lived and worked in and around the Middle East for much of his professional career. He writes about the meeting of the tech and finance worlds.
FTX, Alameda Research to Cough Up $12.7 Billion—What Now for Crypto?
Transformation in the APAC Trading Landscape and Beyond | FMPS:24
Transformation in the APAC Trading Landscape and Beyond | FMPS:24
As the financial services industry experiences rapid and transformative changes, leading fintech experts and policymakers come together to discuss the present and future of retail trading and the evolving regulatory landscape. Join this insightful session for a forward-looking perspective on the trends, innovations, and trader needs that are shaping the future of offerings on a global scale.
Speakers:
Eric Blewitt, CEO, Investment Trends
Rhys Bollen, Senior Executive Leader, Digital Assets, Australian Securities and Investments Commission (ASIC)
Michael Bogoevski, Head of Institutional Sales, CMC Connect
Karin Setchell, General Manager, Product & Investing Solutions, CommSec
#fmps #fmps24 #fmevents #RetailTrading #FintechInnovation #FinancialRegulation #DigitalAssets #GlobalFinance
📣 Stay updated with the latest in finance and trading!
Follow FMevents across our social media platforms for news, insights, and event updates.
Connect with us today:
🔗 LinkedIn: https://www.linkedin.com/showcase/financemagnates-events/
👍 Facebook: https://www.facebook.com/FinanceMagnatesEvents
📸 Instagram: https://www.instagram.com/fmevents_official
🐦 Twitter: https://twitter.com/F_M_events
🎥 TikTok: https://www.tiktok.com/@fmevents_official
▶️ YouTube: https://www.youtube.com/@FinanceMagnates_official
Don't miss out on our latest videos, interviews, and event coverage.
Subscribe to our YouTube channel for more!
As the financial services industry experiences rapid and transformative changes, leading fintech experts and policymakers come together to discuss the present and future of retail trading and the evolving regulatory landscape. Join this insightful session for a forward-looking perspective on the trends, innovations, and trader needs that are shaping the future of offerings on a global scale.
Speakers:
Eric Blewitt, CEO, Investment Trends
Rhys Bollen, Senior Executive Leader, Digital Assets, Australian Securities and Investments Commission (ASIC)
Michael Bogoevski, Head of Institutional Sales, CMC Connect
Karin Setchell, General Manager, Product & Investing Solutions, CommSec
#fmps #fmps24 #fmevents #RetailTrading #FintechInnovation #FinancialRegulation #DigitalAssets #GlobalFinance
📣 Stay updated with the latest in finance and trading!
Follow FMevents across our social media platforms for news, insights, and event updates.
Connect with us today:
🔗 LinkedIn: https://www.linkedin.com/showcase/financemagnates-events/
👍 Facebook: https://www.facebook.com/FinanceMagnatesEvents
📸 Instagram: https://www.instagram.com/fmevents_official
🐦 Twitter: https://twitter.com/F_M_events
🎥 TikTok: https://www.tiktok.com/@fmevents_official
▶️ YouTube: https://www.youtube.com/@FinanceMagnates_official
Don't miss out on our latest videos, interviews, and event coverage.
Subscribe to our YouTube channel for more!
Executive Interviews with Joe Li & Simon Naish | ATFX | FMPS:24
Executive Interviews with Joe Li & Simon Naish | ATFX | FMPS:24
In this Finance Magnates Executive Interview, Joe Li, Chairman at ATFX and Simon Naish, Country Head of Australia at ATFX Connect, discuss ATFX’s strategic growth in the APAC region, particularly focusing on their institutional arm, ATFX Connect. They highlight the importance of Australia as a strategic hub, the challenges of operating in a highly competitive and regulated market, and their plans for regional expansion across APAC. The conversation touches on the integration of advanced technology and multi-asset offerings, the significance of optimal execution tools, and the importance of tailoring solutions to meet the sophisticated demands of institutional clients. They also emphasize their strong regulatory compliance and their commitment to enhancing client experience through innovative tools and infrastructure.
#fmps #fmps24 #fmevents #ATFXConnect #APACFinance #InstitutionalTrading #FinancialTechnology #MarketExpansion
📣 Stay updated with the latest in finance and trading!
Follow FMevents across our social media platforms for news, insights, and event updates.
Connect with us today:
🔗 LinkedIn: https://www.linkedin.com/showcase/financemagnates-events/
👍 Facebook: https://www.facebook.com/FinanceMagnatesEvents
📸 Instagram: https://www.instagram.com/fmevents_official
🐦 Twitter: https://twitter.com/F_M_events
🎥 TikTok: https://www.tiktok.com/@fmevents_official
▶️ YouTube: https://www.youtube.com/@FinanceMagnates_official
Don't miss out on our latest videos, interviews, and event coverage.
Subscribe to our YouTube channel for more!
In this Finance Magnates Executive Interview, Joe Li, Chairman at ATFX and Simon Naish, Country Head of Australia at ATFX Connect, discuss ATFX’s strategic growth in the APAC region, particularly focusing on their institutional arm, ATFX Connect. They highlight the importance of Australia as a strategic hub, the challenges of operating in a highly competitive and regulated market, and their plans for regional expansion across APAC. The conversation touches on the integration of advanced technology and multi-asset offerings, the significance of optimal execution tools, and the importance of tailoring solutions to meet the sophisticated demands of institutional clients. They also emphasize their strong regulatory compliance and their commitment to enhancing client experience through innovative tools and infrastructure.
#fmps #fmps24 #fmevents #ATFXConnect #APACFinance #InstitutionalTrading #FinancialTechnology #MarketExpansion
📣 Stay updated with the latest in finance and trading!
Follow FMevents across our social media platforms for news, insights, and event updates.
Connect with us today:
🔗 LinkedIn: https://www.linkedin.com/showcase/financemagnates-events/
👍 Facebook: https://www.facebook.com/FinanceMagnatesEvents
📸 Instagram: https://www.instagram.com/fmevents_official
🐦 Twitter: https://twitter.com/F_M_events
🎥 TikTok: https://www.tiktok.com/@fmevents_official
▶️ YouTube: https://www.youtube.com/@FinanceMagnates_official
Don't miss out on our latest videos, interviews, and event coverage.
Subscribe to our YouTube channel for more!
Ready to Scale? Regtech in Australia, A Global View | FMPS:24
Ready to Scale? Regtech in Australia, A Global View | FMPS:24
In the effort to elevate Australian fintech on the global stage, RegTech presents a unique and compelling case. Despite the increasing demand for robust compliance solutions, Australia's RegTech sector—ranked third-largest globally—remains underfunded. Join this insightful fireside chat to explore the future of Australia’s RegTech hub and its global potential.
Key discussion points include uncovering the hidden opportunities in RegTech that VCs are overlooking, the necessary steps for increased governmental support, the readiness of the local ecosystem to collaborate across global regulatory regimes, and lessons learned from other leading fintech hubs around the world.
Speakers:
Dickie Currer, National Lead, Tech Australia Advocates
Deborah Young, CEO, The RegTech Association
#fmps #fmps24 #fmevents #RegTech #Fintech #AustralianFintech #GlobalCompliance #TechInnovation
📣 Stay updated with the latest in finance and trading!
Follow FMevents across our social media platforms for news, insights, and event updates.
Connect with us today:
🔗 LinkedIn: https://www.linkedin.com/showcase/financemagnates-events/
👍 Facebook: https://www.facebook.com/FinanceMagnatesEvents
📸 Instagram: https://www.instagram.com/fmevents_official
🐦 Twitter: https://twitter.com/F_M_events
🎥 TikTok: https://www.tiktok.com/@fmevents_official
▶️ YouTube: https://www.youtube.com/@FinanceMagnates_official
Don't miss out on our latest videos, interviews, and event coverage.
Subscribe to our YouTube channel for more!
In the effort to elevate Australian fintech on the global stage, RegTech presents a unique and compelling case. Despite the increasing demand for robust compliance solutions, Australia's RegTech sector—ranked third-largest globally—remains underfunded. Join this insightful fireside chat to explore the future of Australia’s RegTech hub and its global potential.
Key discussion points include uncovering the hidden opportunities in RegTech that VCs are overlooking, the necessary steps for increased governmental support, the readiness of the local ecosystem to collaborate across global regulatory regimes, and lessons learned from other leading fintech hubs around the world.
Speakers:
Dickie Currer, National Lead, Tech Australia Advocates
Deborah Young, CEO, The RegTech Association
#fmps #fmps24 #fmevents #RegTech #Fintech #AustralianFintech #GlobalCompliance #TechInnovation
📣 Stay updated with the latest in finance and trading!
Follow FMevents across our social media platforms for news, insights, and event updates.
Connect with us today:
🔗 LinkedIn: https://www.linkedin.com/showcase/financemagnates-events/
👍 Facebook: https://www.facebook.com/FinanceMagnatesEvents
📸 Instagram: https://www.instagram.com/fmevents_official
🐦 Twitter: https://twitter.com/F_M_events
🎥 TikTok: https://www.tiktok.com/@fmevents_official
▶️ YouTube: https://www.youtube.com/@FinanceMagnates_official
Don't miss out on our latest videos, interviews, and event coverage.
Subscribe to our YouTube channel for more!
Resilience in Trading: From Third Class To World Class | FMPS:24
Resilience in Trading: From Third Class To World Class | FMPS:24
Join Mario Singh, Founder and Chairman of Fullerton Markets, as he shares his life story, highlighting the traits that were required starting without financial knowledge to become a financial and trading expert recognised by world-renowned media like CNBC & Bloomberg.
#fmps #fmps24 #fmevents #trading #onlinetrading #tradingexpert #tradingjourney
📣 Stay updated with the latest in finance and trading!
Follow FMevents across our social media platforms for news, insights, and event updates.
Connect with us today:
🔗 LinkedIn: https://www.linkedin.com/showcase/financemagnates-events/
👍 Facebook: https://www.facebook.com/FinanceMagnatesEvents
📸 Instagram: https://www.instagram.com/fmevents_official
🐦 Twitter: https://twitter.com/F_M_events
🎥 TikTok: https://www.tiktok.com/@fmevents_official
▶️ YouTube: https://www.youtube.com/@FinanceMagnates_official
Don't miss out on our latest videos, interviews, and event coverage.
Subscribe to our YouTube channel for more!
Join Mario Singh, Founder and Chairman of Fullerton Markets, as he shares his life story, highlighting the traits that were required starting without financial knowledge to become a financial and trading expert recognised by world-renowned media like CNBC & Bloomberg.
#fmps #fmps24 #fmevents #trading #onlinetrading #tradingexpert #tradingjourney
📣 Stay updated with the latest in finance and trading!
Follow FMevents across our social media platforms for news, insights, and event updates.
Connect with us today:
🔗 LinkedIn: https://www.linkedin.com/showcase/financemagnates-events/
👍 Facebook: https://www.facebook.com/FinanceMagnatesEvents
📸 Instagram: https://www.instagram.com/fmevents_official
🐦 Twitter: https://twitter.com/F_M_events
🎥 TikTok: https://www.tiktok.com/@fmevents_official
▶️ YouTube: https://www.youtube.com/@FinanceMagnates_official
Don't miss out on our latest videos, interviews, and event coverage.
Subscribe to our YouTube channel for more!
IBs and Brokers: The Good, The Bad, The Ugly | FMPS:24
IBs and Brokers: The Good, The Bad, The Ugly | FMPS:24
For most brokers, IBs and trading educators are invaluable partners, driving highly targeted traffic from key regions. However, without proper management, these relationships can quickly turn sour. In this session, gain an insider’s perspective on the types of licenses IBs need in APAC, the crucial details in IB agreements that both parties must scrutinize, common disputes between IBs and brokers and effective resolutions, and the pros and cons of transitioning from IB to broker.
Speakers:
Melody Gao, Senior Lawyer, Sophie Grace
James Perry-Keene, Head of Strategic Partnerships, Pepperstone
Christopher Balanzategui, CEO, N3tworx
#fmps #fmps24 #fmevents #IBAgreements #BrokerPartnerships #TradingIndustry #APACFinance #FinancialRegulation
📣 Stay updated with the latest in finance and trading!
Follow FMevents across our social media platforms for news, insights, and event updates.
Connect with us today:
🔗 LinkedIn: https://www.linkedin.com/showcase/financemagnates-events/
👍 Facebook: https://www.facebook.com/FinanceMagnatesEvents
📸 Instagram: https://www.instagram.com/fmevents_official
🐦 Twitter: https://twitter.com/F_M_events
🎥 TikTok: https://www.tiktok.com/@fmevents_official
▶️ YouTube: https://www.youtube.com/@FinanceMagnates_official
Don't miss out on our latest videos, interviews, and event coverage.
Subscribe to our YouTube channel for more!
For most brokers, IBs and trading educators are invaluable partners, driving highly targeted traffic from key regions. However, without proper management, these relationships can quickly turn sour. In this session, gain an insider’s perspective on the types of licenses IBs need in APAC, the crucial details in IB agreements that both parties must scrutinize, common disputes between IBs and brokers and effective resolutions, and the pros and cons of transitioning from IB to broker.
Speakers:
Melody Gao, Senior Lawyer, Sophie Grace
James Perry-Keene, Head of Strategic Partnerships, Pepperstone
Christopher Balanzategui, CEO, N3tworx
#fmps #fmps24 #fmevents #IBAgreements #BrokerPartnerships #TradingIndustry #APACFinance #FinancialRegulation
📣 Stay updated with the latest in finance and trading!
Follow FMevents across our social media platforms for news, insights, and event updates.
Connect with us today:
🔗 LinkedIn: https://www.linkedin.com/showcase/financemagnates-events/
👍 Facebook: https://www.facebook.com/FinanceMagnatesEvents
📸 Instagram: https://www.instagram.com/fmevents_official
🐦 Twitter: https://twitter.com/F_M_events
🎥 TikTok: https://www.tiktok.com/@fmevents_official
▶️ YouTube: https://www.youtube.com/@FinanceMagnates_official
Don't miss out on our latest videos, interviews, and event coverage.
Subscribe to our YouTube channel for more!